IDEXX LABORATORIES INC /DE Accrued Liabilities, Current
IDEXX LABORATORIES INC /DE (IDXX) had Accrued Liabilities, Current of $453.17 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Accrued Liabilities, Current $453.17M.
- 2026-03-31: Accrued Liabilities, Current $453.55M.
- 2025-12-31: Accrued Liabilities, Current $530.15M.
- 2025-09-30: Accrued Liabilities, Current $488.86M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $453.17M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $453.55M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $530.15M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $488.86M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $416.98M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $490.69M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $502.12M 10-K · filed 2026-02-20 | |
| 2024-09-30 | $511.05M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $541.12M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $476.25M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $478.71M 10-K · filed 2025-02-21 | |
| 2023-09-30 | $420.31M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $399.43M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $403.60M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $433.66M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $405.99M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $387.51M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $409.56M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $458.91M 10-K · filed 2023-02-16 | |
| 2021-09-30 | $431.05M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $392.68M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $366.88M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $415.65M 10-K · filed 2022-02-16 | |
| 2020-09-30 | $362.33M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $308.77M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $247.18M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $322.94M 10-K · filed 2021-02-12 | |
| 2019-09-30 | $278.63M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $256.33M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $229.13M 10-Q · filed 2019-05-01 | |
| 2019-01-01 | $274.46M 10-K · filed 2020-02-14 | $13.78M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $260.68M 10-K · filed 2020-02-14 | |
| 2018-09-30 | $238.43M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $228.38M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $210.38M 10-Q · filed 2018-05-04 | |
| 2018-01-01 | $254.38M 10-K · filed 2019-02-15 | |
| 2017-12-31 | $253.42M 10-K · filed 2019-02-15 | |
| 2017-09-30 | $220.51M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $210.18M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $174.76M 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $236.13M 10-K · filed 2018-02-16 | |
| 2016-09-30 | $202.07M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $188.84M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $178.27M 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $205.53M 10-K · filed 2017-02-17 | |
| 2015-09-30 | $203.74M 10-Q · filed 2015-10-28 | |
| 2015-06-30 | $190.44M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $177.94M 10-Q · filed 2015-04-28 | |
| 2014-12-31 | $195.35M 10-K · filed 2016-02-17 | |
| 2014-09-30 | $167.45M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $147.25M 10-Q · filed 2014-07-25 | |
| 2014-03-31 | $134.52M 10-Q · filed 2014-04-25 | |
| 2013-12-31 | $148.92M 10-K · filed 2015-02-17 | |
| 2013-09-30 | $134.16M 10-Q · filed 2013-10-22 | |
| 2013-06-30 | $123.47M 10-Q · filed 2013-07-23 | |
| 2013-03-31 | $118.47M 10-Q · filed 2013-04-23 | |
| 2012-12-31 | $137.75M 10-K · filed 2014-02-18 | |
| 2012-09-30 | $134.66M 10-Q · filed 2012-10-19 | |
| 2012-06-30 | $128.48M 10-Q · filed 2012-07-20 | |
| 2012-03-31 | $126.09M 10-Q · filed 2012-04-20 | |
| 2011-12-31 | $141.38M 10-K · filed 2013-02-19 | |
| 2011-09-30 | $136.80M 10-Q · filed 2011-10-21 | |
| 2011-06-30 | $121.90M 10-Q · filed 2011-07-22 | |
| 2011-03-31 | $107.65M 10-Q · filed 2011-04-21 | |
| 2010-12-31 | $118.60M 10-K · filed 2012-02-17 | |
| 2010-09-30 | $108.18M 10-Q · filed 2010-10-22 | |
| 2010-06-30 | $99.63M 10-Q · filed 2010-07-23 | |
| 2009-12-31 | $104.96M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |